Using Peer Mentors to Support PACT Team Efforts to Improve Diabetes Control



Status:Completed
Conditions:Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:30 - 75
Updated:11/2/2018
Start Date:September 1, 2012
End Date:October 8, 2018

Use our guide to learn which trials are right for you!

The purpose of this study is to test the effectiveness of a peer mentor model in a mixed race
population of poorly controlled diabetic Veterans. Also, the study aims to assess the effects
of becoming a mentor on those who originally were mentees. It is expected that participants
in the peer mentoring arms (Arm 2 and 3) will have improved glucose control regardless of
race or ethnicity at the end of the intervention.

The primary objectives of this study are: (1) test the long-term effectiveness of a peer
mentor model on improving glucose control, blood pressure, LDL levels, diabetes mellitus
quality of life, and depression scores in a mixed race population of poorly controlled
diabetic Veterans; (2) test the effectiveness of using former peer mentees as peer mentors as
a means of creating a self-sustaining program; and (3) and test the effects of becoming a
mentor on those who were originally mentees given a growing literature that being a mentor is
good for your health. Secondary objectives include: (1) in those randomized to being a
mentee, explore mentor characteristics associated with improved HbA1c.

This study will be a prospective randomized controlled trial. Outcomes to be measured include
glycosylated hemoglobin, blood pressure, direct LDL, diabetes quality of life and depression.

The trial has two phases. In phase one, patients with poorly controlled diabetes are
randomized to usual care or receiving peer mentoring. In phase two, poorly controlled
diabetics are randomized to usual care or receiving peer mentoring from former mentees.
Former mentees from phase 1 are also randomized such that they will have a 50% chance of
becoming a mentor.

Inclusion Criteria:

Inclusion Criteria:

- All participants must have a diagnosis of Type 2 diabetics.

- Diabetes began after age 30

- Mentees: Have an HbA1c > 8% on 2 different occasions in the course of 24 months, with
at least one measure within 3 months of enrollment

- Mentors for Phase 1: Had an HbA1c of > 8% in the past 3 years and an HbA1c < (or equal
to) 7.5% within 3 months of enrollment

- Mentors for Phase 2: Former mentee

Exclusion Criteria:

Exclusion Criteria:

- Does not speak English

- Unable to understand consents

- Severe speech impediment

- over the age of 75
We found this trial at
1
site
3900 Woodland Avenue
Philadelphia, Pennsylvania 19104
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials